Concepedia

Publication | Open Access

Loss of NEIL3 activates radiotherapy resistance in the progression of prostate cancer

51

Citations

27

References

2021

Year

Abstract

We demonstrated that NEIL3 may serve as a diagnostic or therapeutic target for therapy-resistant patients.

References

YearCitations

Page 1